SecBot SecBot
EFFECT ·Filed Jul 17, 2026

CPRX

CATALYST PHARMACEUTICALS, INC.
BEARISH
Impact 5/10
Horizonweeks Processed4mo ago SEC9999999995-26-002323
Actionable Insight ▼ Bearish

The simultaneous effectiveness of multiple shelf registrations signals Catalyst is prepared to raise capital at any time. Monitor for a subsequent prospectus supplement or 424B filing that would disclose actual offering size and terms, that event would be the real catalyst for price movement. Until then, the overhang may weigh on the stock given the bearish analyst consensus.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK AT ENTRY AT T+5
Entry
$31.49
T+0 close · Jul 17, 2026 · via day close
Latest settled
0.00%
T+5 · $31.49
Vs SPY
+0.59%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Jul 17 $31.49entry
  2. T+1 · 4mo ago 0.00%α +0.16% · $31.49
  3. T+5 · 4mo ago 0.00%α +0.59% · $31.49
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 5w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Catalyst Pharmaceuticals received SEC effectiveness on July 16, 2026 for four separate shelf registration statements (File Nos. 333-215315, 333-170945, 333-151368, 333-240052, and 333-219259), each previously filed as POS AM amendments. This batch of EFFECT notices confirms the company can now sell securities under multiple shelf registrations at any time, creating a potential dilution overhang. The simultaneous effectiveness of multiple shelves suggests preparation for flexible capital raising, though no specific offering size or timing is disclosed in these filings.

Key Facts

  • Four shelf registration statements (File Nos. 333-215315, 333-170945, 333-151368, 333-240052, 333-219259) were declared effective by the SEC on July 16, 2026.
  • Each shelf was preceded by a POS AM (post-effective amendment) filing, indicating updates to previously filed registration statements.
  • No offering size, pricing, or specific security type is disclosed in these EFFECT notices.
  • The company has a $3.9B market cap and analyst consensus is 0% bullish (6 Hold, 1 Sell, 2 Strong Sell).
  • Institutional 13F data shows only $28M in disclosed holdings from top holders, with 2 adds and 1 trim in the most recent quarter.

Financial Impact

Multiple shelf registrations effective, potential dilution overhang, but no specific dollar amount disclosed in these filings.

dilutionshare count

Risk Factors

  • Potential dilutive equity offering at any time under the now-effective shelf registrations
  • Bearish analyst consensus with 0% bullish ratings and 3 sell-equivalent ratings
  • Low institutional ownership ($28M disclosed) suggests limited support from large funds

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 24 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (CPRX), Batch item 19999999995-26-002323
Document: 9999999995-26-002323-index.html9999999995-26-002322
Document: 9999999995-26-002323.txt9999999995-26-002321
EFFECT Filing (CPRX), Batch item 49999999995-26-002322
Document: 9999999995-26-002322-index.html9999999995-26-002322
Document: 9999999995-26-002322.txt9999999995-26-002321
EFFECT Filing (CPRX), Batch item 79999999995-26-002321
Document: 9999999995-26-002321-index.html9999999995-26-002324
Document: 9999999995-26-002321.txt9999999995-26-002323
EFFECT Filing (CPRX), Batch item 109999999995-26-002323
Document: 9999999995-26-002323-index.html9999999995-26-002323
Document: 9999999995-26-002323.txt9999999995-26-002323
EFFECT Filing (CPRX), Batch item 139999999995-26-002322
Document: 9999999995-26-002322-index.html9999999995-26-002323
Document: 9999999995-26-002322.txt9999999995-26-002323
EFFECT Filing (CPRX), Batch item 169999999995-26-002321
Document: 9999999995-26-002321-index.html9999999995-26-002323
Document: 9999999995-26-002321.txt9999999995-26-002323
EFFECT Filing (CPRX), Batch item 199999999995-26-002325
Document: 9999999995-26-002325-index.html9999999995-26-002323
Document: 9999999995-26-002325.txt9999999995-26-002323
EFFECT Filing (CPRX), Batch item 229999999995-26-002324
Document: 9999999995-26-002324-index.html9999999995-26-002323
Document: 9999999995-26-002324.txt9999999995-26-002323

Track record

16 reports on CPRX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +25.72% at T+60 after the Feb 25, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 4, 202612d ago Institutional Cluster Bearish 4/10 No price data
  2. Aug 22, 202612w ago Institutional Cluster Mixed 5/10 No price data
  3. Jul 24, 202616w ago 15-12G Bearish 9/10 Entry $31.49 No price data
  4. Jul 17, 202617w ago EFFECT Bearish 5/10 Viewing Entry $31.49 No price data
  5. Jul 15, 202617w ago 25-NSE Bearish 9/10 Entry $31.49 No price data
  6. Jul 8, 202618w ago 8-K Bullish 6/10 Entry $31.47 No price data
  7. Jun 30, 202619w ago DEFA14A Neutral 3/10 Entry $31.44 No price data
  8. Jun 30, 202619w ago 8-K Neutral 4/10 Entry $31.44 No price data
  9. May 28, 202624w ago PREM14A Bullish 8/10 Entry $31.23 to $31.46 ▲ +0.74% +2.53% vs SPY
  10. May 12, 202626w ago DEFA14A Neutral 3/10 Entry $31.14 to $31.34 ▲ +0.64% +2.37% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 17, 2026